Cell line · CVCL_0153
B-CPAP
Cancer cell line, Homo sapiens. Poorly differentiated thyroid gland carcinoma. 58 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. B-CPAP. Cell lines, record CVCL_0153. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0153
On this page
Cell line
As Cellosaurus gives it.
- Name
- B-CPAP
- Accession
- CVCL_0153
- RRID
- RRID:CVCL_0153
- Synonyms
- BC-PAP, BCPAP
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 76Y
- Category
- Cancer cell line
- Diseases
- Poorly differentiated thyroid gland carcinoma (NCIt C6040); Thyroid carcinoma (ORDO Orphanet_100088)
- Derived from
- Thyroid gland (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Originally classified a thyroid gland papillary carcinoma (PTC) but is now considered to be a poorly differentiated thyroid gland carcinoma (PDTC) (PubMed=23162534). |
Source Cellosaurus
Papers58
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Loss of CSE couples with BRAF V600E to fuel thyroid cancer metastatic progression through zinc-dependent activation of the EMT machinery. | J Exp Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sunitinib enhances cuproptosis induced by copper ionophores via ROS-ATF3-SLC31A1 axis in thyroid Carcinoma. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Roundup® Original DI promotes proliferation in papillary thyroid carcinoma cells: a comparative study highlighting cell-type-dependent effects. | Front Endocrinol (Lausanne) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of ATM reverses radioiodine resistance in differentiated thyroid cancer via genotoxic stress amplification. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Investigating the Role of TNFSF12 in Thyroid Cancer Progression via Single-Cell RNA Sequencing and Integrated Multiomics Analyses. | Mediators Inflamm | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bisphenol A Induces DNA Damage and Differential Cytotoxicity in Thyroid Cells: High-Dose Effects Challenge Regulatory Thresholds. | J Appl Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Clinical Significance for Risk Stratification of Papillary Thyroid Cancer by TUMORFISHER Circulating Tumor Cell Technique. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting EZH2 reverses thyroid cell dedifferentiation and enhances iodide uptake in anaplastic thyroid cancer. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TGF-β1-based restoration of sodium iodide symporter expression in radioiodine-refractory differentiated thyroid cancer via engineered MSCs. | Mol Ther | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 58
See all 58 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | BCPAP-R | CVCL_A8S1 | Cell lines | |
| Derived from it | HyCyte B-CPAP KO-hSLC5A5 | CVCL_F1MW | Cell lines | |
| Derived from it | HyCyte B-CPAP stable cell line for hSLC5A5 overexpression | CVCL_F4QG | Cell lines |
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 305081 | CLS | |
| DSMZ | ACC-273 | DSMZ | |
| Hysigen | TCH-C131 | Hysigen | |
| NCBI_Iran | C596 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0153
GET https://conductscience.org/api/cell-lines/v1/CVCL_0153/papers?page=2